400-9696-311 转1
400-9696-311 转2
400-9696-311 转3
400-9696-311 转4
2020-06-10
针对癌症的生物构建体研发商
医药研发/制造
Sectoral Asset Management;
Sectoral Asset Management;
Omega Funds;
Omega Funds;
BrightEdge Ventures;
Sofinnova Partners;
VenBio Partners;
Clough Capital Partners;
Medixci;
诺和诺德;
F-Prime Capital;
德诚资本;
Longitude Capital
动脉网-最新2026-04-28
动脉网-最新2026-04-28
GlobeNewswire2026-04-28
GlobeNewswire2026-04-28
医药云端工作室2026-04-28
GlobeNewswire2026-04-28
GlobeNewswire2026-04-28
Businesswire2026-04-28
PRNewswire2026-04-28
PRNewswire2026-04-28